Skip to Content

Month: December 2022

HIV vaccine candidate induces immune response in early clinical trial: ‘An important step forward’

By Jacqueline Howard, CNN An experimental HIV vaccine has been found to induce broadly neutralizing antibody precursors among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine, given eight weeks apart, can elicit immune responses against the human immunodeficiency virus. The clinical trial results,

Continue Reading
Skip to content